RetinalGenix Technologies Inc. RTGN
$3.99
-$0.01-0.25%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -49.81% | -19.57% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -48.51% | -5.29% | |||
| Operating Income | 48.51% | 5.29% | |||
| Income Before Tax | 47.94% | 5.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 47.94% | 5.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 47.94% | 5.23% | |||
| EBIT | 48.51% | 5.29% | |||
| EBITDA | 48.51% | 5.29% | |||
| EPS Basic | 48.25% | 5.69% | |||
| Normalized Basic EPS | 48.22% | 5.74% | |||
| EPS Diluted | 48.25% | 5.69% | |||
| Normalized Diluted EPS | 48.22% | 5.74% | |||
| Average Basic Shares Outstanding | 0.28% | 0.61% | |||
| Average Diluted Shares Outstanding | 0.28% | 0.61% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||